Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLATFORM-COVID study
2022-500678-33-00Phase 4Withdrawn
- Sponsor
- Maastricht University
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of montelukast in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Maastricht University. Primary endpoint: Time to recovery within 28 days. Planned start Jul 2022; status: withdrawn.
02
Drugs
montelukast
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2022-500678-33-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-500678-33-00.